CRISPR Therapeutics AG (CRSP)

CIK 1674416 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CRISPR Therapeutics AG.

Recent SEC filings

FiledFormAccession number
Nov 2, 20268-K0001193125-26-443644
Nov 2, 202630001193125-26-443954
Nov 2, 202610-Q0001193125-26-443665
Oct 28, 202640001193125-26-436436
Oct 28, 202640001193125-26-436441
Oct 28, 202640001193125-26-436443
Oct 28, 202640001193125-26-436444
Oct 21, 202640001193125-26-428010
Oct 21, 202630001193125-26-428002
Oct 20, 202640001193125-26-426878
Oct 19, 20268-K0001193125-26-425243
Oct 16, 202640001193125-26-424317
Oct 15, 202640001193125-26-423057
Oct 15, 202640001193125-26-423056
Oct 14, 20261440001950047-26-010218
Oct 8, 202640001193125-26-418101
Oct 6, 20261440001950047-26-010087
Sep 24, 202640001193125-26-401237
Sep 22, 20261440001950047-26-009755
Sep 21, 202640001193125-26-396944
Sep 21, 202640001193125-26-396935
Sep 17, 20261440001950047-26-009604
Aug 14, 2026SCHEDULE 13G/A0000940594-26-000049
Aug 11, 202640001193125-26-345111
Aug 3, 20268-K0001193125-26-330644